Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome -: Trends in treatment over time in 440 patients

Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome -: Trends in treatment over time in 440 patients
复制标题

DOI:
10.1097/sla.0b013e3181557e47
复制
发表时间:
2008-01-01
期刊:
影响因子:
9
通讯作者:
D'Angelica, Michael
D'Angelica, Michael
中科院分区:
医学1区
文献类型:
--
作者:
Gold, Jason S.;Are, Chandrakanth;D'Angelica, Michael

文献摘要

被引文献

相似文献

目的:本研究的目的是确定结直肠癌双侧肝转移患者肝切除的结果。我们的目的是评估技术方法随时间的演变以及与发病率、死亡率和肿瘤学结果的相关性。背景数据摘要:尽管肝切除术治疗孤立性结直肠肝转移瘤被认为在可行的情况下是有益的,但双侧肝转移瘤的切除术存在独特的技术问题,并且通常与更具侵袭性的肿瘤生物学相关。关于这部分患者取得的结果,鲜有专门报道。方法:回顾了前瞻性维护的数据库,该数据库记录了 11 年期间在单一机构接受肝切除术的患者的数据。结果:443 例结直肠癌双侧肝转移瘤(440 名患者)完成了切除,主要并发症发生率为 29%,90 天死亡率为 5.4%。 Kaplan-Meier 估计 5 年疾病特异性生存率为 30%,5 年无复发生存率为 18%。手术技术发生了变化。随着时间的推移,人们会转向保留实质的方法,更多地使用同时进行的多个肝脏切除、楔形切除和消融就证明了这一点。同样,主要肝切除术的使用也有所减少。这与死亡率降低相关,而疾病特异性生存率或肝脏复发没有变化。结论:双侧结直肠肝转移瘤的切除可以实现可接受的发病率、死亡率和肿瘤学结果。增加使用实质保留方法可降低死亡率,同时不影响癌症相关结果。
Objective: The aim of this study was to determine the results of liver resection for patients with bilateral hepatic metastases from colorectal cancer. We aimed to assess the evolution of the technical approach over time and correlations with morbidity, mortality, and oncologic outcome.Summary Background Data: Although hepatic resection for isolated colorectal metastases to the liver is thought to be beneficial when feasible, resection of bilateral liver metastases carries unique technical issues and is often associated with more aggressive tumor biology. Little has been written specifically about the results achieved in this subset of patients.Methods: Data from a prospectively maintained database of patients undergoing hepatic resection at a single institution over an 11-year time period were reviewed.Results: Resection of bilateral liver metastases from colorectal cancer was accomplished in 443 cases (440 patients) with a 29% incidence of major complications and a 5.4% 90-day mortality. Kaplan-Meier estimated 5-year disease-specific survival was 30% and 5-year recurrence-free survival was 18%. Operative technique changed. over time toward a parenchymal-sparing approach as evidenced by the greater use of multiple simultaneous liver resections, wedge resections, and ablations. Similarly, there was a decrease in the use of major hepatectomies. This correlated with decreased mortality without change in disease-specific survival or liver recurrence.Conclusions: Resection of bilateral colorectal liver metastases can be accomplished with acceptable morbidity, mortality, and oncologic results. Increased use of a parenchymal-sparing approach is associated with decreased mortality without compromise in cancer-related outcome.